{
    "Rank": 401,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT05396612",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "UPCC 19121"
                },
                "SecondaryIdInfoList": {
                    "SecondaryIdInfo": [
                        {
                            "SecondaryId": "850338",
                            "SecondaryIdType": "Other Identifier",
                            "SecondaryIdDomain": "University of Pennsylvania"
                        }
                    ]
                },
                "Organization": {
                    "OrgFullName": "Abramson Cancer Center at Penn Medicine",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Role of the Immune Environment in Response to Therapy in Breast Cancer",
                "OfficialTitle": "Role of the Immune Environment in Response to Therapy in Breast Cancer"
            },
            "StatusModule": {
                "StatusVerifiedDate": "April 2023",
                "OverallStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "October 3, 2022",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "December 31, 2032",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "December 31, 2032",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "May 5, 2022",
                "StudyFirstSubmitQCDate": "May 25, 2022",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "May 31, 2022",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "April 11, 2023",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "April 13, 2023",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Jennifer Zhang",
                    "ResponsiblePartyInvestigatorTitle": "Assistant Professor of Surgery",
                    "ResponsiblePartyInvestigatorAffiliation": "Abramson Cancer Center at Penn Medicine"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Abramson Cancer Center at Penn Medicine",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Cancer",
                        "ER Positive Breast Cancer",
                        "HER2-negative Breast Cancer",
                        "TNBC - Triple-Negative Breast Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Immune microenvironment"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Control"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples With DNA",
                    "BioSpecDescription": "Tissue from breast tumors removed as standard of care treatment for breast cancer."
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "300",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.",
                            "InterventionDescription": "Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver."
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Collecting, processing and archiving breast cancer tumor tissues",
                            "PrimaryOutcomeDescription": "This study will collect and analyze tumor samples from women diagnosed with primary breast cancer. The investigators will dissociate fresh tumor samples and analyze single cell suspensions by flow cytometry. Percentage of dendritic cell and T cell subsets and dendritic cell and T cell activation markers will be compared between breast cancer subtypes (HR+HER2-, HER2+, triple negative). Percentage of dendritic cell and T cell subsets and dendritic cell and T cell activation markers will be compared between HR+HER2- untreated breast cancers compared to HR+HER2- chemotherapy treated breast cancers.",
                            "PrimaryOutcomeTimeFrame": "Through study completion, average of 2 years"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Associating breast cancer dendritic cell infiltrate with outcome",
                            "SecondaryOutcomeDescription": "We will perform studies to associate dendritic cell infiltration and activation markers with patient outcome, including disease free survival, distant disease free survival, and overall survival.",
                            "SecondaryOutcomeTimeFrame": "5 years"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion criteria:\n\nWomen 18 years of age or older with non-metastatic breast cancer undergoing surgical resection in the University of Pennsylvania Health System.\n\nExclusion criteria:\n\nMales Children Pregnant individuals",
                "HealthyVolunteers": "No",
                "Gender": "Female",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "Women 18 years of age or older undergoing surgery for breast cancer.",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Julia T. Lewandowski",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "215-662-2861",
                            "CentralContactEMail": "Julia.Lewandowski@Pennmedicine.upenn.edu"
                        },
                        {
                            "CentralContactName": "Jennifer Zhang, MD",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "215-615-6810",
                            "CentralContactEMail": "Jennifer.Zhang@Pennmedicine.upenn.edu"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Jennifer Zhang, MD",
                            "OverallOfficialAffiliation": "Abramson Cancer Center",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Abramson Cancer Center",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Philadelphia",
                            "LocationState": "Pennsylvania",
                            "LocationZip": "19104",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "No",
                "IPDSharingDescription": "Individual participant data will not be shared with other researchers."
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000064726",
                            "ConditionMeshTerm": "Triple Negative Breast Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000001941",
                            "ConditionAncestorTerm": "Breast Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M30063",
                            "ConditionBrowseLeafName": "Triple Negative Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "TNBC - Triple-Negative Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}